Diana Baralle Selected Research

Carcinogenesis

1/2012

Evolutionary constraint helps unmask a splicing regulatory region in BRCA1 exon 11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Baralle Research Topics

Disease

7	Neoplasms (Cancer) 11/2021 - 08/2012
4	Breast Neoplasms (Breast Cancer) 11/2021 - 08/2012
3	Rare Diseases (Rare Disease) 09/2023 - 01/2021
3	COVID-19 01/2022 - 01/2021
2	Neurodevelopmental Disorders 04/2024 - 01/2020
2	Microcephaly 01/2021 - 01/2020
2	Growth Disorders 01/2019 - 04/2014
1	Fibrosis (Cirrhosis) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023
1	Malformations of Cortical Development 01/2023
1	Oculocutaneous albinism type 1 01/2022
1	Oculocutaneous albinism type 1B 01/2022
1	Human Influenza (Influenza) 01/2022
1	Septo-Optic Dysplasia 01/2022
1	Coloboma (Colobomas) 01/2022
1	Optic Atrophy 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Cataract (Cataracts) 01/2021
1	Infections 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Cleft Palate (Palate, Cleft) 01/2020
1	Anodontia (Hypodontia) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Megalencephaly 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020
1	Arthrogryposis 12/2019
1	Ciliopathies 11/2019
1	Sotos Syndrome 01/2019
1	Kabuki syndrome 01/2019
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2017
1	Ocular Albinism 01/2017
1	Albinism 01/2017
1	Intellectual Disability (Idiocy) 04/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 04/2014
1	Carcinogenesis 01/2012
1	King Denborough syndrome 06/2011
1	Muscular Diseases (Myopathy) 06/2011
1	Malignant Hyperthermia 06/2011
1	Central Core Myopathy (Central Core Disease) 06/2011
1	Vitelliform Macular Dystrophy 10/2004
1	Neurofibromatosis-Noonan syndrome 05/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2004
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	Protein Isoforms (Isoforms)IBA 11/2021 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2014
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022 - 01/2017
2	Melanins (Melanin)IBA 01/2022 - 01/2017
2	RNA Precursors (Precursor, mRNA)IBA 11/2021 - 01/2020
1	Small Nuclear RNA (snRNA)IBA 04/2024
1	CollagenIBA 12/2023
1	Untranslated Regions (Untranslated Region)IBA 09/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	EnzymesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Initiator Codon (Start Codon)IBA 01/2022
1	CytokinesIBA 01/2022
1	VaccinesIBA 01/2022
1	Nucleosomes (Nucleosome)IBA 01/2022
1	NucleotidesIBA 01/2022
1	InterferonsIBA 01/2021
1	Coat Protein Complex I (COPI)IBA 01/2021
1	RNA Splicing FactorsIBA 01/2020
1	SpectrinIBA 01/2020
1	Retinaldehyde (Retinal)IBA 11/2019
1	DNA Methyltransferase 3AIBA 01/2019
1	Histone MethyltransferasesIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	BRCA1 ProteinIBA 01/2016
1	MethyltransferasesIBA 04/2014
1	Histones (Histone)IBA 04/2014
1	A-Form DNA (A-DNA)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Trans-Activators (Trans-Acting Factor)IBA 01/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2011
1	BestrophinsIBA 10/2004
1	Neurofibromin 1 (Neurofibromin)IBA 05/2003

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2017
1	Genomic Medicine 12/2020